SCHEMBL29015206

SCHEMBL29015206

CC(C)CCCC(C)[C@H]1CC[C@H]2[C@@H]3CC(=O)C4CCCC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.74

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
USP2 O75604 3/20 0.74
NPC1L1 Q9UHC9 2/20 0.74
LMNA P02545 2/20 0.74
SRD5A1 P18405 6/20 0.55
SRD5A2 P31213 3/20 0.55
FNTA P49354 3/20 0.55
FNTB P49356 3/20 0.55
CDC25A P30304 4/20 0.54
CDC25B P30305 1/20 0.53
CYP2D6 P10635 1/20 0.51
CYP2C19 P33261 1/20 0.51
ABCB1 P08183 1/20 0.51
OSBP P22059 1/20 0.51
RORC P51449 1/20 0.51
OSBP2 Q969R2 1/20 0.51
CYP46A1 Q9Y6A2 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL863638 1.00 USP2 (0.74) USP2NPC1L1LMNASRD5A1SRD5A2
SCHEMBL14924215 1.00 USP2 (0.74) USP2NPC1L1LMNASRD5A1SRD5A2
SCHEMBL248175 0.90 LMNA (0.63) USP2NPC1L1LMNASRD5A1SRD5A2
SCHEMBL10584542 0.87 LMNA (0.57) USP2NPC1L1LMNASRD5A1SRD5A2
SCHEMBL26653759 0.87 NPC1L1 (0.60) USP2NPC1L1LMNAFNTAFNTB
SCHEMBL10698627 0.86 LMNA (0.55) USP2NPC1L1LMNA
SCHEMBL29289385 0.86 GPBAR1 (0.69) USP2NPC1L1LMNAFNTAFNTB
SCHEMBL2482340 0.86 USP2 (0.73) USP2NPC1L1LMNASRD5A1SRD5A2
SCHEMBL2482342 0.86 USP2 (0.73) USP2NPC1L1LMNASRD5A1SRD5A2
SCHEMBL248173 0.85 NPC1L1 (0.72) USP2NPC1L1LMNASRD5A1SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116096429-A Base editing of PCSK9 and methods of use thereof for treating diseases 维乎医疗有限公司 2023-05-09 CN disclosed
CN-116096883-A Base editing of ANGPTL3 and methods of treating diseases using the same 维乎医疗有限公司 2023-05-09 CN disclosed